Alan Cooper, lead study author, discussed follow-up research steps that would seek to validate CD5 immunohistochemistry positive diffuse large B-cell lymphoma types that could benefit from specific targeted therapies.
Alan Cooper, lead study author, discussed follow-up research steps that would seek to validate CD5 immunohistochemistry positive diffuse large B-cell lymphoma types that could benefit from specific targeted therapies.
Alan Cooper, lead study author,...